Complications of double j urethral cathater. Complications of genitourinary prosthetic devices, implants and grafts
Conditions
Interventions
Intervention 1: The control group patients after discharge - the day after surgery - and for a period of 48 hours, antibiotic cefixime 400, on a daily basis and 10 ibuprofen housing 400, one pill, giv
Treatment - Drugs
The control group patients after discharge - the day after surgery - and for a period of 48 hours, antibiotic cefixime 400, on a daily basis and 10 ibuprofen housing 400, one pill, given every 8 hours
In the intervention group, in addition to these drugs, pills urtidin pharmaceutical barij company, a dosage of one pill every 8 hours, for a period of fifteen days it will be given.
Sponsors
Sharoud University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: the size of the stone and the location of the stone which measures (less than ten mm) and place the stone below the junction (urethral pelvic); patients suffering a urethral stone, just on one side and those who bilateral urethral stones or kidney stones are excluded; age between 20-70 years old(due to a higher incidence of kidney stones in this age range); no history of urologic manipulation in the past few years is a another criteria. Exclusion criteria: history of benign prostatic hypertrophy; previous surgery on the bladder or lower urinary tract; bladder stones; active urinary tract infection; lack of proper placement of the double J catheter; neurogenic bladder and the lack of the next visit.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gross hematuria. Timepoint: 3 and 7 days after start of treatment. Method of measurement: questionnaire.;Dysuria. Timepoint: 3, 7 and 15 days after start of treatment. Method of measurement: questionnaire.;Frequency. Timepoint: 3, 7 and 15 days after start of treatment. Method of measurement: questionnaire.;Pain. Timepoint: 3, 7 and 15 days after start of treatment. Method of measurement: VAS score.;Microscopic hematuria. Timepoint: 15 days after start of treatment. Method of measurement: urine analysis.;Edema and inflammation of the mucus of bladder and ureter. Timepoint: 15 days after start of treatment. Method of measurement: cystoscopy.;Urinary infection. Timepoint: 15 days after start of treatment. Method of measurement: urine cuture.;Fever. Timepoint: 3, 7 and 15 days after start of treatment. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeed Heydari
Clinical Research Development, Sharoud University of Medical Sciences
Outcome results
None listed